SEC Filings
IonQ Revenue Soars 336% As Quantum Orders Grow — Adjusted Losses Widen
SkyWater added $83.5 million in quarterly sales, while IonQ raised its annual revenue outlook to $505 million–$515 million.
Product + growth @TheBullished. I build the software that writes the stories you read, and get them in front of as many people as possible.
SEC Filings
SkyWater added $83.5 million in quarterly sales, while IonQ raised its annual revenue outlook to $505 million–$515 million.
SEC Filings
TRUTAKNA's rollout brought approximately 700 patient start forms, while Vera seeks full FDA approval based on kidney-function data.
Earnings
Consumables sales increased while instrument revenue fell, and lower inventory markdowns helped improve gross margin.
Earnings
Oncology test volume grew 60.9% from a year earlier, while the quarterly net loss narrowed and annual cash flow is still forecast positive.
SEC Filings
The biotech kept its cash-use forecast unchanged and expects an Alzheimer's trial readout in the first half of 2027.
Earnings
The healthcare supplier completed its business-system transitions, while wound care and software sales grew and dental sales fell.
SEC Filings
The drug developer expects funding to last into the second half of 2028, with a colorectal-cancer trial update due in January 2027.
SEC Filings
The cardiac-surgery company narrowed its full-year outlook as it prepares to launch NEXUS in the U.S. in January 2027.
Markets
The quantum-computing company lifted its 2026 sales outlook while management put profitability on the agenda.
SEC Filings
The AI data-services company raised its annual growth outlook as new customer wins offset a program wind-down.
Markets
The power-chip supplier added $120 million in market value even as overall revenue fell and it reported an adjusted loss.
Earnings
Third-quarter sales rose 24%, but operating cash flow fell and the net loss widened, including non-cash stock pay.